CereVasc, Inc. announced the initial results of its United States pilot clinical study of the CereVasc eShunt system in the tre ...

Akura Medical, Inc., a privately held portfolio company of Shifamed LLC that is developing treatments for venous thromboembolis ...

Penumbra recently announced the launch of the Lightning Bolt 12 and the Lightning Bolt 6X with Trax systems, the next ...

Surmodics, Inc. announced the early clinical use of its Pounce XL thrombectomy system, which is currently in limited market rel ...

Penumbra announced that it has launched the Element vascular access system, a laser-cut hypotube sheath designed for treating ...

Cagent Vascular, Inc. announced the launch of its Serranator SL-Pro percutaneous transluminal angioplasty (PTA) serration ballo ...

In a multicenter, retrospective review of patients admitted with intact and ruptured abdominal aortic aneurysms (AAAs), ...

Imperative Care, Inc. announced that it has received FDA 510(k) clearance of the company’s Zoom system. The comprehensive ...

AngioDynamics, Inc. announced the commencement of the AMBITION BTK multicenter randomized controlled trial (RCT), which will ...

Amplitude Vascular Systems (AVS), developer of the Pulse intravascular lithotripsy (PIVL) platform for the treatment of ...

Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the ...

Front Line Medical Technologies Inc. COBRA-OS REBOA (large vessel balloon occlusion device; 4-F; 25-mm-diameter balloon; guidewire-free) Aortic Temporary occlusion of large blood vessels and/or ...